시장보고서

상품코드

1762365

종양학 방사선 치료 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 방사선 유형별, 치료별, 최종사용자별, 지역별, 예측(2025-2034년)

Radiation Therapy in the Oncology Market Size, Share, Trends, & Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), By Therapy, By End-User, and By Region - Market Forecast, 2025-2034

발행일: 2025년 05월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 130 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 종양학 분야 방사선 치료 세계 시장 규모는 2034년까지 154억 3,000만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 상세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.

종양학 분야의 방사선 치료 시장은 암 치료 및 관리를 위한 고에너지 이온화 방사선의 활용을 포함합니다. 이 치료법에서는 주변 건강한 조직과 장기의 손상을 최소화하면서 암세포의 박멸과 증식 억제를 목적으로 악성 종양에 정확하게 방사선을 조사했습니다. 리니어릭을 이용한 외부조사치료(EBRT), 체내에 방사성 선원을 설치하는 체내조사치료(Brachytherapy), 전신을 순환하는 방사성 물질을 이용한 전신조사치료 등 다양한 방사선원과 조사기술이 이용되고 있습니다. 방사선종양학 분야는 첨단 영상진단, 치료계획 소프트웨어, 전문 의료지식을 통합하여 다양한 종양 유형과 병기에 걸친 암환자의 치료 결과를 최적화합니다.

이 시장은 전 세계 암 발병률 증가와 방사선 조사 기술의 지속적인 발전에 힘입어 광범위한 방사선 종양학 전망에서 중요한 부문이 되고 있습니다. 시장 개요는 방사선 치료를 개별 환자 및 종양 특성에 맞게 조정하는 맞춤 의료의 확산과 같은 요인에 의해 영향을 받는 역동적인 환경을 보여줍니다. 강도변조방사선치료(IMRT), 영상유도방사선치료(IGRT), 양성자치료, 자기공명유도방사선치료(MRgRT)와 같은 기술 혁신은 치료의 정확성과 효과를 높여 시장 개척에 박차를 가하고 있습니다. 또한, 신흥국의 의료 인프라 확대와 저침습적 암 치료 옵션에 대한 수요 증가는 암 분야 방사선 치료의 전반적인 시장 성장과 시장 잠재력에 크게 기여하고 있습니다.

종양학 방사선 치료 시장 보고서 하이라이트

방사선 유형별로 보면, 광범위한 암종에 적용할 수 있고 이 기술을 갖춘 치료 센터가 널리 보급되어 있기 때문에 외부 방사선 치료이 현재 세계에서 가장 높은 시장 점유율을 차지하고 있습니다. 비침습적 특성과 확립된 임상 프로토콜이 방사선 치료 시장에서 지배적인 위치에 기여하고 있습니다.

치료별로는 강도변조방사선치료(IMRT)가 현재 가장 큰 시장 점유율을 차지하고 있습니다. 이는 주로 빔의 강도를 조절하면서 종양의 모양에 따라 방사선량을 정확하게 조절할 수 있는 첨단 기능이 다양한 암 치료에 널리 채택되어 국소 제어를 개선하는 효과가 입증되었기 때문입니다.

최종 사용자별로는 병원 및 의료 연구 기관이 현재 가장 큰 시장 점유율을 차지하고 있습니다. 이는 주로 방사선 치료가 기본 치료 수단인 병원이 종합적인 암 치료 서비스를 제공하고, 병원이 많은 환자를 치료하고, 의료 연구 기관이 조사 활동을 수행하기 때문입니다.

지역별로는 북미가 현재 암 방사선 치료 시장에서 가장 큰 점유율을 차지하고 있습니다. 아시아태평양은 예측 기간 동안 종양 방사선 치료 시장에서 가장 높은 성장률을 보일 것으로 예측됩니다.

암 분야 방사선 치료 시장에 적극적으로 진출하고 있는 주요 기업 중 인수되지 않은 기업으로는 Accuray Incorporated, Elekta AB, Mevion Medical Systems, Siemens Healthineers (which includes Varian Medical Systems), IBA Worldwide, ViewRay Technologies Inc, Perspective Therapeutics Inc (formerly Isoray Inc), Hitachi Ltd (part of Hitachi High-Tech Corporation), Sumitomo Heavy Industries Ltd, Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG) 등이 있습니다.

주요 조사 결과
서론
- 종양학 방사선 치료 시장 평가 : 지역별, 2020-2034년
북미
- 북미 : 방사선 유형별, 2020-2034년
- 북미 : 치료별, 2020-2034년
- 북미 : 최종사용자별, 2020-2034년
- 미국
- 캐나다
유럽
- 유럽 : 방사선 유형별, 2020-2034년
- 유럽 : 치료별, 2020-2034년
- 유럽 : 최종사용자별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 방사선 유형별, 2020-2034년
- 아시아태평양 : 치료별, 2020-2034년
- 아시아태평양 : 최종사용자별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 방사선 유형별, 2020-2034년
- 중동 및 아프리카 : 치료별, 2020-2034년
- 중동 및 아프리카 : 최종사용자별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 방사선 유형별, 2020-2034년
- 라틴아메리카 : 치료별, 2020-2034년
- 라틴아메리카 : 최종사용자별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제9장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제10장 기업 개요

Accuray Incorporated
Carl Zeiss Meditec AG(a subsidiary of Carl Zeiss AG)
Elekta AB
Hitachi Ltd(part of Hitachi High-Tech Corporation)
IBA Worldwide
Mevion Medical Systems
Perspective Therapeutics Inc(formerly Isoray Inc)
Siemens Healthineers(which includes Varian Medical Systems)
Sumitomo Heavy Industries Ltd
ViewRay Technologies Inc

LSH 25.07.10

The global Radiation therapy in the oncology market size is expected to reach USD 15.43 billion by 2034, according to a new study by Polaris Market Research. The report "Radiation Therapy in the Oncology Market Size, Share, Trends, Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), Therapy, End-User, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Radiation therapy in the oncology market encompasses the utilization of high-energy ionizing radiation to treat and manage cancer. This therapeutic modality involves precisely delivering radiation to malignant tumors, aiming to eradicate cancerous cells or impede their growth while minimizing damage to surrounding healthy tissues and organs. Various radiation sources and delivery techniques are employed, including external beam radiation therapy (EBRT) using linear accelerators, internal radiation therapy (brachytherapy) involving the placement of radioactive sources within the body, and systemic radiation therapy using radioactive substances that circulate throughout the body. The radiation oncology field integrates sophisticated imaging, treatment planning software, and specialized medical expertise to optimize treatment outcomes for cancer patients across diverse tumor types and stages.

The market is a critical segment within the broader radiation oncology landscape, driven by the increasing global incidence of cancer and continuous advancements in radiation delivery technologies. The market overview reveals a dynamic environment influenced by factors such as the growing adoption of personalized medicine, which tailors radiation treatments to individual patient and tumor characteristics. Technological innovations, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), proton therapy, and magnetic resonance-guided radiation therapy (MRgRT), are enhancing treatment precision and efficacy, thereby fueling market development. Furthermore, the expanding healthcare infrastructure in emerging economies and the rising demand for minimally invasive cancer treatment options contribute significantly to the overall market growth and market potential of radiation therapy in oncology.

Radiation Therapy in the Oncology Market Report Highlights:

By radiation type, the external beam radiation segment currently holds the highest market share globally due to its broad applicability across a wide range of cancer types and the widespread availability of treatment centers equipped with this technology. Its non-invasive nature and established clinical protocols contribute to its dominant position in the radiation therapy market.

By therapy, intensity-modulated radiation therapy (IMRT) presently commands the largest market share. This is primarily because of its advanced capability to precisely conform the radiation dose to the tumor's shape while modulating the beam's intensity, leading to widespread adoption across various cancer treatments and its proven efficacy in improving local control.

By end-user, the hospitals & medical research institutes segment currently accounts for the largest market share. This is mainly due to the comprehensive cancer care services offered by hospitals, where radiation therapy is a fundamental treatment modality, along with the significant patient volumes they handle and the research activities undertaken by medical research institutes.

By region, North America currently holds the largest market share in the radiation therapy in the oncology market. The Asia Pacific region is anticipated to exhibit the highest growth rate in the radiation therapy in the oncology market over the forecast period.

The major players actively involved in the radiation therapy in the oncology market, who have not been acquired, include Accuray Incorporated, Elekta AB, Mevion Medical Systems, Siemens Healthineers (which includes Varian Medical Systems), IBA Worldwide, ViewRay Technologies Inc, Perspective Therapeutics Inc (formerly Isoray Inc), Hitachi Ltd (part of Hitachi High-Tech Corporation), Sumitomo Heavy Industries Ltd, and Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG).

Polaris Market Research has segmented the Radiation Therapy in the Oncology market report based on radiation type, therapy, end-user, and region:

By Radiation Type Outlook (Revenue - USD Billion, 2020-2034)

External Beam Radiation

Internal Beam Radiation

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

Stereotactic Radiosurgery (SRS)

Image-Guided Radiation Therapy (IGRT)

Intensity-Modulated Radiation Therapy (IMRT)

Volumetric-Modulated Arc Therapy (VMAT)

Brachytherapy

By End-User Outlook (Revenue - USD Billion, 2020-2034)

Hospitals & Medical Research Institutes

Specialized Radiotherapy Centers

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Radiation Therapy in the Oncology Market Insights

4.1. Radiation Therapy in the Oncology Market - Market Snapshot
4.2. Radiation Therapy in the Oncology Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Global Cancer Incidence Driving Market Demand
  - 4.2.1.2. Technological Advancements Enhancing Treatment Efficacy
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost of radiation equipment
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Radiation Therapy in the Oncology Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Radiation Therapy in the Oncology Market, by Radiation Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
5.3. External Beam Radiation
- 5.3.1. Global Radiation Therapy in the Oncology Market, by External Beam Radiation, by Region, 2020-2034 (USD Billion)
5.4. Internal Beam Radiation
- 5.4.1. Global Radiation Therapy in the Oncology Market, by Internal Beam Radiation, by Region, 2020-2034 (USD Billion)

6. Global Radiation Therapy in the Oncology Market, by Therapy

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
6.3. Stereotactic Radiosurgery (SRS)
- 6.3.1. Global Radiation Therapy in the Oncology Market, by Stereotactic Radiosurgery (SRS), by Region, 2020-2034 (USD Billion)
6.4. Image-Guided Radiation Therapy (IGRT)
- 6.4.1. Global Radiation Therapy in the Oncology Market, by Image-Guided Radiation Therapy (IGRT), by Region, 2020-2034 (USD Billion)
6.5. Intensity-Modulated Radiation Therapy (IMRT)
- 6.5.1. Global Radiation Therapy in the Oncology Market, by Intensity-Modulated Radiation Therapy (IMRT), by Region, 2020-2034 (USD Billion)
6.6. Volumetric-Modulated Arc Therapy (VMAT)
- 6.6.1. Global Radiation Therapy in the Oncology Market, by Volumetric-Modulated Arc Therapy (VMAT), by Region, 2020-2034 (USD Billion)
6.7. Brachytherapy
- 6.7.1. Global Radiation Therapy in the Oncology Market, by Brachytherapy, by Region, 2020-2034 (USD Billion)

7. Global Radiation Therapy in the Oncology Market, by End-User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
7.3. Hospitals & Medical Research Institutes
- 7.3.1. Global Radiation Therapy in the Oncology Market, by Hospitals & Medical Research Institutes, by Region, 2020-2034 (USD Billion)
7.4. Specialized Radiotherapy Centers
- 7.4.1. Global Radiation Therapy in the Oncology Market, by Specialized Radiotherapy Centers, by Region, 2020-2034 (USD Billion)

8. Global Radiation Therapy in the Oncology Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Radiation Therapy in the Oncology Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Radiation Therapy in the Oncology Market - North America
- 8.3.1. North America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.3.3. North America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.3.4. Radiation Therapy in the Oncology Market - U.S.
  - 8.3.4.1. U.S.: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.3.5. Radiation Therapy in the Oncology Market - Canada
  - 8.3.5.1. Canada: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
8.4. Radiation Therapy in the Oncology Market - Europe
- 8.4.1. Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.4.3. Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.4. Radiation Therapy in the Oncology Market - UK
  - 8.4.4.1. UK: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.5. Radiation Therapy in the Oncology Market - France
  - 8.4.5.1. France: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.6. Radiation Therapy in the Oncology Market - Germany
  - 8.4.6.1. Germany: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.7. Radiation Therapy in the Oncology Market - Italy
  - 8.4.7.1. Italy: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.8. Radiation Therapy in the Oncology Market - Spain
  - 8.4.8.1. Spain: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.9. Radiation Therapy in the Oncology Market - Netherlands
  - 8.4.9.1. Netherlands: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.10. Radiation Therapy in the Oncology Market - Russia
  - 8.4.10.1. Russia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.4.11. Radiation Therapy in the Oncology Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
8.5. Radiation Therapy in the Oncology Market - Asia Pacific
- 8.5.1. Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.4. Radiation Therapy in the Oncology Market - China
  - 8.5.4.1. China: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.5. Radiation Therapy in the Oncology Market - India
  - 8.5.5.1. India: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.6. Radiation Therapy in the Oncology Market - Malaysia
  - 8.5.6.1. Malaysia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.7. Radiation Therapy in the Oncology Market - Japan
  - 8.5.7.1. Japan: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.8. Radiation Therapy in the Oncology Market - Indonesia
  - 8.5.8.1. Indonesia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.9. Radiation Therapy in the Oncology Market - South Korea
  - 8.5.9.1. South Korea: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.10. Radiation Therapy in the Oncology Market - Australia
  - 8.5.10.1. Australia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.5.11. Radiation Therapy in the Oncology Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
8.6. Radiation Therapy in the Oncology Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.4. Radiation Therapy in the Oncology Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.5. Radiation Therapy in the Oncology Market - UAE
  - 8.6.5.1. UAE: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.6. Radiation Therapy in the Oncology Market - Israel
  - 8.6.6.1. Israel: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.7. Radiation Therapy in the Oncology Market - South Africa
  - 8.6.7.1. South Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.6.8. Radiation Therapy in the Oncology Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
8.7. Radiation Therapy in the Oncology Market - Latin America
- 8.7.1. Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.4. Radiation Therapy in the Oncology Market - Mexico
  - 8.7.4.1. Mexico: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.5. Radiation Therapy in the Oncology Market - Brazil
  - 8.7.5.1. Brazil: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.6. Radiation Therapy in the Oncology Market - Argentina
  - 8.7.6.1. Argentina: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)
- 8.7.7. Radiation Therapy in the Oncology Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Radiation Therapy in the Oncology Market, by Radiation Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Radiation Therapy in the Oncology Market, by Therapy, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Radiation Therapy in the Oncology Market, by End-User, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Accuray Incorporated
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Carl Zeiss Meditec AG (a subsidiary of Carl Zeiss AG)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Elekta AB
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Hitachi Ltd (part of Hitachi High-Tech Corporation)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. IBA Worldwide
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Mevion Medical Systems
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Perspective Therapeutics Inc (formerly Isoray Inc)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Siemens Healthineers (which includes Varian Medical Systems)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Sumitomo Heavy Industries Ltd
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. ViewRay Technologies Inc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development

종양학 방사선 치료 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 방사선 유형별, 치료별, 최종사용자별, 지역별, 예측(2025-2034년)

Radiation Therapy in the Oncology Market Size, Share, Trends, & Industry Analysis Report: By Radiation Type (External Beam Radiation and Internal Beam Radiation), By Therapy, By End-User, and By Region - Market Forecast, 2025-2034

종양학 방사선 치료 시장 보고서 하이라이트

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 종양학 세계의 방사선 치료 시장 인사이트

제5장 세계의 종양학 방사선 치료 시장 : 방사선 유형별

제6장 세계의 종양학 방사선 치료 시장 : 치료별

제7장 세계의 종양학 방사선 치료 시장 : 최종사용자별

제8장 세계의 종양학 방사선 치료 시장 : 지역별